Hoppenot Herve bought MAZE
June 8, 2026 · Form 4 insider transaction
Hoppenot Herve bought 18,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,000
Price
$0.00
Total value
N/A
InsiderHoppenot Herve
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 8, 2026
Filing dateJune 10, 2026
Shares owned after18,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.